Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: cardiac arrhythmias, menopause knowledge, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, April 28, 2025 - Friday, May 2, 2025), and click each link to read and watch anything you may have missed.
Cardiac complications are a leading cause of maternal mortality in the United States. To address this, researchers at the University of California, San Francisco (UCSF) are leading an innovative study, BRITE-MOM, that uses wearable ECG monitors to detect arrhythmias during pregnancy and postpartum.
Nicky Herrick, MD, a third-year cardiovascular disease fellow at UCSF, and Anushree Agarwal, MD, MBBS, associate professor of Medicine and Research director of the Adult Congenital Heart Disease and Cardio-Obstetrics Program at UCSF, are co-leading the prospective study. “We were using ambulatory ECG monitors to prospectively look for arrhythmias during pregnancy and postpartum,” said Herrick. “We're currently enrolling women during pregnancy. We've enrolled 29 so far.”
Click here for the full video.
In a recent interview with Contemporary OB/GYN, Elizabeth Gandee, APRN-CNP, nurse practitioner in women's health at The Ohio State University Wexner Medical Center, discussed findings from a nationwide survey on women’s perceptions of perimenopause and menopause.
The survey, which included 1,068 women aged 18 to 60 across the United States, focused on understanding women's awareness and attitudes toward the perimenopausal transition and associated health practices. Several key insights emerged, pointing to significant gaps in knowledge and misconceptions surrounding this life stage.
Click here for the full video.
In a recent interview with Contemporary OB/GYN, Lisa Becht, MD, FACOG, double board certified fertility specialist with HRC Fertility, highlighted HRC Fertility's recent survey to gauge public awareness of fertility issues, particularly concerning anti-müllerian hormone (AMH) testing.
Becht explained that AMH is a blood test used to evaluate a woman's ovarian reserve, offering insight into egg quantity relative to age. Despite its clinical value, 63% of adults surveyed had never heard of AMH. Although AMH testing has been available for many years, it has only become more accessible to the general public in the last 5 to 10 years. Increasing awareness of AMH can empower women to make proactive fertility decisions, such as considering egg freezing if their ovarian reserve is low.
Click here for the full video.
The American Urological Association (AUA), Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), and American Urogynecologic Society (AUGS) have published a new guideline with evidence-based recommendations for the diagnosis and treatment of Genitourinary syndrome of menopause (GSM).
Diagnosis is based on patient-reported symptoms, including dryness, irritation, dyspareunia, and urinary complaints such as dysuria, urgency, and recurrent urinary tract infections. Physical signs—such as labial atrophy, introital stenosis, or changes in vaginal pH—may support the diagnosis but are not required. Clinicians are advised not to rely on hormone levels for diagnosis or management decisions.
Click here for the full article.
In an interview with Contemporary OB/GYN, Joy Windley, CLC, postpartum doula at Boram Care, discussed the shortcomings in public health systems when it comes to supporting pregnant and postpartum women.
Windley highlighted a critical gap in postpartum care preparation. While much attention is given to prenatal care and birth, there is insufficient focus on what happens to the mother after delivery. Many women are left unprepared for the physical and emotional realities of the postpartum period, which can be shocking and overwhelming, especially given that maternal health follow-ups often don’t occur until 4 to 6 weeks after birth. This is particularly concerning because many maternal complications and deaths occur in the early weeks following hospital discharge.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen